Clinical Decision Support for Opioid Use Disorders in Medical Settings: Usability Testing in an EMR (COMPUTE)
Clinical Decision Support for Opioid Use Disorders in Medical Settings: Pilot Usability Testing in an EMR
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Minnesota
-
Bloomington, Minnesota, United States, 55425
- HealthPartners
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Be an MD, Doctor of Osteopathy, Nurse Practitioner or Physician's Assistant engaged in independent primary care of adults at HealthPartners or Park Nicollet
- Have at least schedule 3 DEA prescribing privileges
- Voluntarily provide written informed consent to participate in this study
Exclusion Criteria:
- Less than half-time clinical primary care responsibilities
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Waivered Providers Receive the Opioid Wizard
All providers who have a buprenorphine waiver will receive the OUD clinical decision support tool (Opioid Wizard).
|
The Opioid Wizard is an OUD clinical decision support tool for primary care providers.
|
|
No Intervention: Does not Receive the Opioid Wizard
All non-buprenorphine waivered providers will be randomized to receive or not receive the Opioid Wizard.
This arm of providers will continue to treat their patients as usual.
|
|
|
Experimental: Non-Waivered Providers who receive Opioid Wizard
All non-buprenorphine waivered providers will be randomized to receive or not receive the Opioid.
This arm of providers will receive the OUD clinical decision support tool (Opioid Wizard).
|
The Opioid Wizard is an OUD clinical decision support tool for primary care providers.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intervention PCP Confidence in Assessing and Treating OUD
Time Frame: This outcome measure was calculated at approximately month 10 of the pilot study
|
# of intervention PCPs who report feeling "moderately" or "very" confident in assessing and treating OUD.
|
This outcome measure was calculated at approximately month 10 of the pilot study
|
|
Intervention PCP Likeliness to Recommend Use of the OUD-CDS
Time Frame: This was calculated after PCP surveys were completed, approximately month 10
|
# of PCPs with CDS access who rate the OUD-CDS >4 on a 5-point Likert scale of likeliness to recommend use of the tool to their colleagues.
The scale ranges from 1-"not at all likely" to 5-"very likely," with higher values representing a higher likelihood of recommending the OUD-CDS to other colleagues.
|
This was calculated after PCP surveys were completed, approximately month 10
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Compare Pre- and Post-intervention Rates of OUD Diagnosis in High-risk Patients.
Time Frame: This was calculated at the end of the pilot study (month 8).
|
Calculate and compare the number of patients diagnosed with OUD pre- and post-intervention.
This will be presented as rate of OUD diagnoses per patient year.
|
This was calculated at the end of the pilot study (month 8).
|
|
Compare Pre- and Post-intervention Rates of Medication-assisted Therapy (MAT) Use.
Time Frame: This was calculated at the end of the pilot study (month 8).
|
Calculate and compare the rate of MAT use among patients with OUD pre- and post-intervention.
This is presented as a pre/post ratio of MAT rx per patient year.
|
This was calculated at the end of the pilot study (month 8).
|
|
Compare Post-intervention Referral Patterns Between Intervention and Control Groups
Time Frame: This was calculated at the end of the pilot study (month 8).
|
Calculate and compare how often patients diagnosed with OUD are referred to specialty care or inpatient treatment post-intervention.
Compare these rates between intervention and control groups.
|
This was calculated at the end of the pilot study (month 8).
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 0076-ot
- 3UG1DA040316-03S1 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.